TY - JOUR
T1 - Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway
T2 - an evolutionary perspective
AU - Folkesson, Anders
AU - Jelsbak, Lars
AU - Yang, Lei
AU - Johansen, Helle Krogh
AU - Ciofu, Oana
AU - Høiby, Niels
AU - Molin, Søren
PY - 2012
Y1 - 2012
N2 - The airways of patients with cystic fibrosis (CF) are nearly always infected with many different microorganisms. This environment offers warm, humid and nutrient-rich conditions, but is also stressful owing to frequent antibiotic therapy and the host immune response. Pseudomonas aeruginosa is commonly isolated from the airways of patients with CF, where it most often establishes chronic infections that usually persist for the rest of the lives of the patients. This bacterium is a major cause of mortality and morbidity and has therefore been studied intensely. Here, we discuss how P. aeruginosa evolves from a state of early, recurrent intermittent colonization of the airways of patients with CF to a chronic infection state, and how this process offers opportunities to study bacterial evolution in natural environments. We believe that such studies are valuable not only for our understanding of bacterial evolution but also for the future development of new therapeutic strategies to treat severe chronic infections.
AB - The airways of patients with cystic fibrosis (CF) are nearly always infected with many different microorganisms. This environment offers warm, humid and nutrient-rich conditions, but is also stressful owing to frequent antibiotic therapy and the host immune response. Pseudomonas aeruginosa is commonly isolated from the airways of patients with CF, where it most often establishes chronic infections that usually persist for the rest of the lives of the patients. This bacterium is a major cause of mortality and morbidity and has therefore been studied intensely. Here, we discuss how P. aeruginosa evolves from a state of early, recurrent intermittent colonization of the airways of patients with CF to a chronic infection state, and how this process offers opportunities to study bacterial evolution in natural environments. We believe that such studies are valuable not only for our understanding of bacterial evolution but also for the future development of new therapeutic strategies to treat severe chronic infections.
U2 - 10.1038/nrmicro2907
DO - 10.1038/nrmicro2907
M3 - Journal article
C2 - 23147702
SN - 1740-1526
VL - 10
SP - 841
EP - 851
JO - Nature Reviews. Microbiology
JF - Nature Reviews. Microbiology
IS - 12
ER -